12:00 AM
Nov 22, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Genoptix, HistoRx sales and marketing update

Genoptix launched NexCourse BCa by AQUA technology in the U.S. The tests are for confirmatory estrogen receptor, progesterone receptor, and EGF receptor 2...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >